Literature DB >> 18302826

Provider-initiated HIV testing and counseling in TB clinical settings: tools for program implementation.

N N Bock1, P Nadol, M Rogers, M A Fenley, J Moore, B Miller.   

Abstract

In countries with high HIV prevalence, up to 80% of tuberculosis (TB) patients also have human immunodeficiency virus (HIV) infection. HIV testing and counseling needs to be more feasible and accessible to all people in settings with a generalized HIV epidemic, but particularly to those likely to have HIV infection and who need care and treatment. Implementing provider-initiated and -delivered HIV testing and counseling (PITC) in clinical settings where patients have symptoms and signs consistent with HIV-related disease, including TB, is therefore a priority. We describe a new tool that has been developed to assist countries in planning and implementing PITC in TB clinical settings. The materials include a template for national guidance for the PITC program and procedures, a training curriculum for clinic staff and job aids including a script that assist clinicians in communicating appropriate pre- and post-test information to their TB patients, including the benefits to HIV-infected TB patients of knowing their status so they can obtain HIV care and treatment and prevent the spread of HIV.

Entities:  

Mesh:

Year:  2008        PMID: 18302826

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  9 in total

Review 1.  PEPFAR support for the scaling up of collaborative TB/HIV activities.

Authors:  Andrea A Howard; Michel Gasana; Haileyesus Getahun; Anthony Harries; Stephen D Lawn; Bess Miller; Lisa Nelson; Joseph Sitienei; William L Coggin
Journal:  J Acquir Immune Defic Syndr       Date:  2012-08-15       Impact factor: 3.731

2.  Tuberculosis patients' reasons for, and suggestions to address non-uptake of HIV testing: a cross-sectional study in the Free State Province, South Africa.

Authors:  N Gladys Kigozi; J Christo Heunis; Edwin Wouters; Henriëtte S van den Berg
Journal:  BMC Health Serv Res       Date:  2011-05-20       Impact factor: 2.655

3.  The whole is greater than the sum of the parts: recognising missed opportunities for an optimal response to the rapidly maturing TB-HIV co-epidemic in South Africa.

Authors:  Rubeshan Perumal; Nesri Padayatchi; Ellen Stiefvater
Journal:  BMC Public Health       Date:  2009-07-16       Impact factor: 3.295

4.  The Prevalence of Tb in HIV Patients and Risk Factor With Frequent Referral (Iran, 2009-10).

Authors:  Narmela Rabirad; Esmaeil Mohammad Nejad; Mohammad Reza Hadizadeh; Jamaloddin Begjan; Seyyedeh Roghayeh Ehsani
Journal:  Iran Red Crescent Med J       Date:  2013-01-05       Impact factor: 0.611

5.  Barriers for introducing HIV testing among tuberculosis patients in Jogjakarta, Indonesia: a qualitative study.

Authors:  Yodi Mahendradhata; Riris Andono Ahmad; Pierre Lefèvre; Marleen Boelaert; Patrick Van der Stuyft
Journal:  BMC Public Health       Date:  2008-11-12       Impact factor: 3.295

6.  Implementing a provider-initiated testing and counselling (PITC) intervention in Cape town, South Africa: a process evaluation using the normalisation process model.

Authors:  Natalie Leon; Simon Lewin; Catherine Mathews
Journal:  Implement Sci       Date:  2013-08-26       Impact factor: 7.327

7.  Provider-initiated HIV testing and counselling in Rwanda: acceptability among clinic attendees and workers, reasons for testing and predictors of testing.

Authors:  Felix R Kayigamba; Mirjam I Bakker; Judith Lammers; Veronicah Mugisha; Emmanuel Bagiruwigize; Anita Asiimwe; Maarten F Schim van der Loeff
Journal:  PLoS One       Date:  2014-04-17       Impact factor: 3.240

8.  HIV Infection and AIDS in Sub-Saharan Africa: Current Status, Challenges and Opportunities.

Authors:  Ayesha B M Kharsany; Quarraisha A Karim
Journal:  Open AIDS J       Date:  2016-04-08

9.  Does provider-initiated HIV testing and counselling lead to higher HIV testing rate and HIV case finding in Rwandan clinics?

Authors:  Felix R Kayigamba; Daniëla Van Santen; Mirjam I Bakker; Judith Lammers; Veronicah Mugisha; Emmanuel Bagiruwigize; Ludwig De Naeyer; Anita Asiimwe; Maarten F Schim Van Der Loeff
Journal:  BMC Infect Dis       Date:  2016-01-25       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.